Termination of Registration of a Class of Security Under Section 12(b) (15-12b)
August 14 2017 - 7:01AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 15
CERTIFICATION
AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION
12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE
REPORTS UNDER
SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File
Number 001-32715
Interleukin
Genetics, Inc.
(Exact Name
of Registrant as specified in its charter)
135 Beaver
Street, Waltham, MA 02452 (781) 398-0700
(Address, including
zip code, and telephone number, including area code, of registrant’s principal executive offices)
All authorized
Preferred and Common stock
(Title of each
lass of securities covered by this Form)
None
(Titles of all
other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place
an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)
Rule 12g-4(a)(2)
Rule 12h-3(b)(1)(i)
Rule 12h-3(b)(1)(ii)
Rule 15d-6
Rule 15d-22(b)
|
x
¨
x
¨
¨
¨
|
Approximate number of holders of record
as of the certification or notice date: 127
Pursuant to the requirements
of the Securities Exchange Act of 1934 (Name of registrant as specified in charter) has caused this certification/notice to be
signed on its behalf by the undersigned duly authorized person.
|
|
|
|
Date: August 14, 2017
|
By:
|
/s/ Barry Kallander
|
|
|
Title
|
President
|
|